Ameriprise is being priced like an insurer while increasingly operating like a capital-light, high-ROE wealth compounder—with buybacks turning valuation upside into a second engine of returns.
Overview
Ameriprise (AMP) enters 2026 at a strategic inflection point, having executed a disciplined transformation from a legacy insurance-centric conglomerate into a wealth-management-led, capital-light franchise. Q3 2025 results exemplify this shift: adjusted operating EPS was $9.92 (+12% YoY) and total AUMA/A reached a record $1.7T. Despite the Advice & Wealth Management segment now generating ~65% of adjusted operating earnings and producing ROE above 50% (52.8% ex-AOCI), the stock still trades near ~13x forward earnings—well below wealth peers like LPL and Schwab (~18x–23x). The report argues this persistent “conglomerate discount” creates an arbitrage: investors can buy a high-quality, high-margin wealth compounding engine at insurance-like multiples, creating a “double-engine” return profile (earnings growth plus multiple expansion potential). The 2026 macro setup is framed as constructive but uneven (“fits and starts”), with ~2.5% GDP growth and anticipated Fed easing; rate cuts may pressure cash sweep spreads, but typically support AUM-driven fee revenue via higher asset values. A defining element of the thesis is capital allocation: Ameriprise returned $3.1B over the last twelve months through Q3’25 (~90% of operating earnings), reduced share count by >20% in five years, and authorized another $4.5B of repurchases through 2027—providing a durable EPS floor and reinforcing shareholder alignment.